Voycheva, C.; Popova, T.; Slavkova, M.; Tzankova, V.; Stefanova, D.; Tzankova, D.; Spassova, I.; Kovacheva, D.; Tzankov, B.
Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro. Bioengineering 2023, 10, 637.
https://doi.org/10.3390/bioengineering10060637
AMA Style
Voycheva C, Popova T, Slavkova M, Tzankova V, Stefanova D, Tzankova D, Spassova I, Kovacheva D, Tzankov B.
Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro. Bioengineering. 2023; 10(6):637.
https://doi.org/10.3390/bioengineering10060637
Chicago/Turabian Style
Voycheva, Christina, Teodora Popova, Marta Slavkova, Virginia Tzankova, Denitsa Stefanova, Diana Tzankova, Ivanka Spassova, Daniela Kovacheva, and Borislav Tzankov.
2023. "Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro" Bioengineering 10, no. 6: 637.
https://doi.org/10.3390/bioengineering10060637
APA Style
Voycheva, C., Popova, T., Slavkova, M., Tzankova, V., Stefanova, D., Tzankova, D., Spassova, I., Kovacheva, D., & Tzankov, B.
(2023). Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro. Bioengineering, 10(6), 637.
https://doi.org/10.3390/bioengineering10060637